Chang, Q., Zhang, Y., Xu, J., Zhong, R., Qiang, H., Zhang, B., . . . Chu, T. (2019). First‐line pemetrexed/carboplatin or cisplatin/bevacizumab compared with paclitaxel/carboplatin/bevacizumab in patients with advanced non‐squamous non‐small cell lung cancer with wild‐type driver genes: A real‐world study in China. Thorac Cancer.

Chang, Qing, Yanwei Zhang, Jianlin Xu, Runbo Zhong, Huiping Qiang, Bo Zhang, Baohui Han, Jialin Qian, and Tianqing Chu. "First‐line Pemetrexed/carboplatin or Cisplatin/bevacizumab Compared With Paclitaxel/carboplatin/bevacizumab in Patients With Advanced Non‐squamous Non‐small Cell Lung Cancer With Wild‐type Driver Genes: A Real‐world Study in China." Thorac Cancer 2019.

Chang, Qing, et al. "First‐line Pemetrexed/carboplatin or Cisplatin/bevacizumab Compared With Paclitaxel/carboplatin/bevacizumab in Patients With Advanced Non‐squamous Non‐small Cell Lung Cancer With Wild‐type Driver Genes: A Real‐world Study in China." Thorac Cancer 2019.